In announcing RFK Jr. as having a significant role in healthcare in his administration, he has targeted healthcare in America as a prime candidate for major change.

Kennedy Jr. is part of President-elect Donald Trump‘s transition team, how should investors think about his potential influence in the healthcare space? Probably with less trepidation than some appear to be feeling,

Robert F. Kennedy Jr. has spent years questioning the federal agencies in charge of vaccine production and safety. Now he is poised to potentially oversee those agencies in a second Trump administration,

RFK Jr. has said Trump promised him “control of the public health agencies,” including the National Institutes of Health and the Centers for Disease Control and Prevention. He’s talked about cleaning up “corruption” at those agencies and reorienting them towards a chronic disease focus (in a page on his MAHA website that has since been scrubbed).

Robert F. Kennedy Jr., who is lined up to advise the incoming Trump administration on its health policy agenda, has floated broad plans to “make America healthy again.”

A doctor fears that an RFK Jr.-influenced Trump White House will discourage vaccination and block the release of data showing the disastrous consequences.

The president-elect has lots of plans to Make America Great Again. One plan is to set Kennedy loose to mess with the fragile US health system. This would include plans to protect women from their own bad choices.

Robert F. Kennedy Jr., the former independent presidential candidate, is reviewing candidate resumes for the top jobs at the U.S. government’s health agencies in Donald Trump’s incoming administration,